Medisol Plus LLC

McKesson Corporation delivers connective health care solutions that ensure the financial success of physicians and hospitals. A leader in business services and technology solutions for the health care industry, McKesson provides solutions to reimbursement inefficiencies that hamper health care providers. The company delivers revenue cycle and resource management solutions, which include enterprise staff and patient scheduling, as well as access, receivables and performance management. These connective health care solutions help health care organizations increase revenue and decrease costs. McKesson Corporation enables these organizations to improve their bottom line with enterprise solutions. Its solutions use a combination of technology, best practices and business intelligence that streamlines processes to increase reimbursement. John H. Hammergren has been the chief executive officer of McKesson for more than seven years. He has been with the health care equipment company for over 10 years. Hammergren earned a BS degree from the University of Minnesota, and a MBA from Xavier University. McKesson Corporation has a location in San Francisco; Richmond, Va.; and Carrollton, Texas.

Pernix Therapeutics is an integrated specialty pharmaceutical company with development and commercial capabilities focused primarily on the pediatric market. Since its foundation, the company has focused on the acquisition, development, marketing and distribution of pharmaceutical products that provide timely and cost effective market entry through various regulatory pathways. All of its products and strategies are focused on creating solid intellectual property to protect the investment and development of the company s products. Products provided by Pernix Therapeutics include Cedax, QuinZyme, ReZyst IM and Upper Respiratory products.